Literature DB >> 10576128

Improved recovery of Mycobacterium tuberculosis from pleural aspirates: bedside inoculation, heparinized containers and liquid culture media.

A F Cheng1, V H Tai, M S Li, C H Chan, C F Wong, W W Yew, M Hui, C Y Chan, J C Lee.   

Abstract

The effects of bedside inoculation, heparinized containers and liquid culture media on the recovery of Mycobacterium tuberculosis from pleural aspirates were evaluated in this study. Of 155 patients, 63 were diagnosed to have pleural effusion tuberculous in origin. The overall recovery of M. tuberculosis was 57.1%. Bedside inoculation of the specimens produced a significantly higher yield than laboratory inoculation using non-heparinized specimens. When the pleural aspirates were transported in heparinized containers, the recovery rate was comparable to that from bedside inoculation, but lower when non-heparinized containers were used. No significant difference was found in recovery rate between the two liquid media, but the rate was significantly higher with the use of liquid media than conventional solid media. Thus, bedside inoculation of pleural aspirates, use of heparinized containers for transport for delayed inoculation in the laboratory and use of liquid culture media are recommended.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10576128     DOI: 10.1080/00365549950164012

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  Impact of Implementation of an Automated Liquid Culture System on Diagnosis of Tuberculous Pleurisy.

Authors:  Byung Hee Lee; Seong Hoon Yoon; Hye Ju Yeo; Dong Wan Kim; Seung Eun Lee; Woo Hyun Cho; Su Jin Lee; Yun Seong Kim; Doosoo Jeon
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

2.  Letter to the editor: Respective Contribution of Liquid and Solid Media to Mycobacterial Yields from Pleural Fluid in Tuberculous Pleural Effusion.

Authors:  Chang Ho Kim; Seung Ick Cha; Jaehee Lee
Journal:  J Korean Med Sci       Date:  2015-11-30       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.